DexCom (NASDAQ:DXCM) Upgraded to Buy at StockNews.com

StockNews.com upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a hold rating to a buy rating in a research report report published on Monday. A number of other analysts have also recently commented on the stock. Wells Fargo & Company increased their price target on shares of DexCom from $110.00 to $136.00 and gave […]

Related Keywords

United States ,Raymond James ,Jeremem Sylvain ,Mitsubishi Ufj ,Kokusai Asset Management Co ,Wells Fargo Company ,Jpmorgan Chase Co ,Dexcom Inc ,Morgan Stanley ,Capital Group Private Client Services Inc ,Dexcom Company Profile ,Intelligence Driven Advisers ,Free Report ,Moderate Buy ,Get Free Report ,Driven Advisers ,Group Private Client Services ,Asset Management ,Dexcom Share ,Dexcom Real Time ,Dexcom Daily ,Dexcom ,Nasdaq Dxcm ,Dxcm ,Medical ,25213110 ,Upgrade ,Stocknews Com ,